多参数磁共振应优先于直肠指检用于前列腺癌局部分期与风险分层
这项荷兰多中心研究纳入2017–2018年新诊断的1683例前列腺癌患者,分别用直肠指检(DRE)和多参数磁共振(mp-MRI)进行风险分组。mp-MRI导致29%患者升期、3%降期,升期与治疗强化几率显著升高相关(OR 3.5,95%CI 1.9–6.5);mp-MRI检测≥T3a的敏感性高于DRE(51% vs 12%),特异性较低(82% vs 97%)。结论认为mp-MRI应作为临床肿瘤分期的首选工具。
要点
- mp-MRI用于风险分层时约1/3患者升期,升期与治疗强化几率升高相关。
- mp-MRI检测非器官局限病变(≥T3a)的敏感性高于DRE,但特异性较低。
- mp-MRI应优先于DRE用于前列腺癌局部分期和风险分类。
核心结论
- 使用mp-MRI肿瘤分期进行前列腺癌风险分类可使约1/3患者升期,且mp-MRI检测非器官局限病变优于DRE,应作为确定临床肿瘤分期的首选工具。
研究设计与样本
- 纳入2017至2018年荷兰7家教学医院新诊断的前列腺癌患者,共1683例,分别基于DRE或mp-MRI信息进行两次风险分组。
- 在行机器人辅助根治性前列腺切除术的患者中评估DRE和mp-MRI检测非器官局限病变(≥T3a)的诊断准确性。
主要发现
- mp-MRI分期导致493/1683(29%)患者升期,43/1683(3%)患者降期。
- mp-MRI升期与治疗强化的显著更高几率相关(OR 3.5,95%CI 1.9–6.5)。
- mp-MRI上≥T3a是风险组升期最常见原因(77%)。
- mp-MRI检测≥T3a的敏感性高于DRE(51% vs 12%,P<.001),特异性低于DRE(82% vs 97%,P<.001)。
- mp-MRI的≥T3a真阳性和真阴性预测累积率显著高于DRE(67% vs 58%,P<.001)。
关键数值与推荐
- 风险分组分别基于DRE或mp-MRI信息进行两次分类。
- 以非器官局限病变(stage ≥T3a)为检测目标,比较DRE与mp-MRI的敏感性和特异性。
临床怎么用
- 在前列腺癌局部分期和风险分类中优先采用mp-MRI而非DRE。
- mp-MRI升期提示可能需要治疗强化,应结合分期结果调整治疗决策。
- 解读mp-MRI分期时需注意其特异性低于DRE,避免过度分期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the impact of multiparametric magnetic resonance imaging (mp-MRI) local tumor staging on prostate cancer risk stratification and choice of treatment. MATERIALS AND METHODS: Prostate cancer patients, newly diagnosed from 2017 to 2018 at 7 Dutch teaching hospitals were included. Risk group classification was done twice, using either digital rectal examination (DRE) or mp-MRI information. Risk group migration and rates of treatment intensification associated with mp-MRI upstaging were established. Diagnostic accuracy measures for the detection of nonorgan-confined disease (stage ≥T3a), for both DRE and mp-MRI, were assessed in patients undergoing robot-assisted radical prostatectomy. RESULTS: A total of 1683 patients were included. Upstaging due to mp-MRI staging occurred in 493 of 1683 (29%) patients and downstaging in 43 of 1683 (3%) patients. Upstaging was associated with significant higher odds for treatment intensification (odds ratio [OR]: 3.5 95% confidence interval [CI] 1.9-6.5). Stage ≥T3a on mp-MRI was the most common reason for risk group upstaging (77%). Sensitivity for the detection of stage ≥T3a was higher for mp-MRI compared to DRE (51% vs 12%, P <.001), whereas specificity was lower (82% vs 97%, P <.001). Mp-MRI resulted in a significantly higher cumulative rate of true positive and true negative stage ≥T3a predictions compared with DRE (67% vs 58%, P <.001). CONCLUSION: Use of mp-MRI tumor stage for prostate cancer risk classification leads to upstaging in 1 of 3 patients. Mp-MRI enables superior detection of nonorgan-confined disease compared with DRE, and should be the preferred tool for determining clinical tumor stage.
引用
- Soeterik TFW, van Melick HHE, Dijksman LM, et al. Multiparametric Magnetic Resonance Imaging Should Be Preferred Over Digital Rectal Examination for Prostate Cancer Local Staging and Disease Risk Classification. Urology. 2020. PMID: 33129868. doi:10.1016/j.urology.2020.08.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。